Published in J Clin Pathol on December 01, 1983
Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrob Agents Chemother (1986) 1.32
Tolerance to penicillin in streptococci of viridans group. J Clin Pathol (1989) 1.30
Oxacillin killing curve patterns of Staphylococcus aureus isolates by agar dilution plate count method. Antimicrob Agents Chemother (1987) 1.05
Ampicillin killing curve patterns for ampicillin-susceptible nontypeable Haemophilus influenzae strains by the agar dilution plate count method. Antimicrob Agents Chemother (1990) 0.83
Reverse inoculum effect in bactericidal activity and other variables affecting killing of group B streptococci by penicillin. Antimicrob Agents Chemother (1985) 0.82
A new type of penicillin resistance of Staphylococcus aureus. Lancet (1977) 9.15
Interaction of penicillin with the bacterial cell: penicillin-binding proteins and penicillin-sensitive enzymes. Bacteriol Rev (1974) 7.49
The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria. Annu Rev Microbiol (1979) 5.33
Incidence and characteristics of antibiotic-tolerant strains of Staphylococcus aureus. Antimicrob Agents Chemother (1978) 4.46
A rapid, inexpensive bacterial count technique using agar droplets. J Appl Bacteriol (1971) 4.06
Tolerance in Staphylococcus aureus. Lancet (1979) 3.60
Tolerant response of Streptococcus sanguis to beta-lactams and other cell wall inhibitors. Antimicrob Agents Chemother (1977) 3.17
A twelve channel bacterial growth monitoring system. Biomed Eng (1973) 3.07
Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis. Ann Intern Med (1980) 2.16
Penicillin tolerance in group B streptococci isolated from infected neonates. J Infect Dis (1981) 1.75
Penicillin-resistant and penicillin-tolerant mutants of group A Streptococci. Antimicrob Agents Chemother (1982) 1.36
Penicillin tolerance of human isolates of group C streptococci. Antimicrob Agents Chemother (1981) 1.28
Penicillin tolerance and bacterial endocarditis. Lancet (1980) 1.22
Antimicrobial tolerance in group G streptococci. Lancet (1980) 1.12
Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis. Antimicrob Agents Chemother (1983) 1.06
Penicillin tolerance in Streptococcus faecalis. Lancet (1980) 1.03
Screening for penicillin tolerance in viridans streptococci by a simple disk method. J Clin Microbiol (1982) 0.84
Endocarditis due to viridans-type streptococci tolerant to beta-lactam antibiotics: therapeutic problems. Br Med J (Clin Res Ed) (1982) 0.82
Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies. J Infect Dis (1973) 4.44
The effect of osmolality on the response of Escherichia coli and Proteus mirabilis to penicillins. Br J Exp Pathol (1972) 3.96
Trimodal response of Escherichia coli and Proteus mirabilis to penicillins. Nature (1970) 3.12
A twelve channel bacterial growth monitoring system. Biomed Eng (1973) 3.07
A comparison of the effects of ampicillin on Escherichia coli and proteus mirabilis. J Med Microbiol (1969) 2.97
FL 1060: a new beta-lactam antibiotic with novel properties. J Clin Pathol (1973) 2.95
Requirements for comparing the performance of finite element models of biological structures. J Theor Biol (2008) 2.55
In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance. J Infect Dis (1981) 2.44
Activities of newer quinolones against Legionella group organisms. Lancet (1983) 2.36
Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle. Chemotherapy (1975) 2.19
Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom Med (1997) 2.19
Mucopeptide hydrolases and bacterial "persisters". Lancet (1972) 2.15
Treatment of "bacterial cystitis" in fully automatic machanical models simulating conditions of bacterial growth in the urinary bladder. Br J Exp Pathol (1973) 1.95
The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci. J Antimicrob Chemother (1987) 1.89
Costs of a healthy diet: analysis from the UK Women's Cohort Study. Public Health Nutr (1999) 1.79
The responses of Escherichia coli to nalidixic acid. Chemotherapy (1978) 1.78
Rapid and definitive detection of Salmonella in foods by PCR. Lett Appl Microbiol (1998) 1.73
The two sites of penicillin action in Escherichia coli. J Infect Dis (1973) 1.71
Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis. Lancet (1995) 1.65
An in vitro model of the urinary bladder. J Antimicrob Chemother (1978) 1.62
Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency. Antimicrob Agents Chemother (1980) 1.61
The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder. Br J Exp Pathol (1974) 1.60
Resistance categories of enterobacteria to beta-lactam antibiotics. J Infect Dis (1975) 1.47
Sex differences in risk factors, treatment and mortality after acute myocardial infarction: an observational study. J Epidemiol Community Health (2000) 1.43
Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli. J Clin Pathol (1976) 1.41
Hepatic UDP-glucuronyltransferase in Wistar and Gunn rats--in vitro activation by diethylnitrosamine. Biochem Biophys Res Commun (1968) 1.41
Expression of the P2X(2) receptor subunit of the ATP-gated ion channel in the cochlea: implications for sound transduction and auditory neurotransmission. J Neurosci (1999) 1.40
Factors influencing the activity of the trometamol salt of fosfomycin. Eur J Clin Microbiol (1986) 1.38
Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol (2000) 1.34
Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis. J Antimicrob Chemother (1996) 1.32
The response of Staphylococcus aureus to benzylpenicillin. Br J Exp Pathol (1979) 1.31
An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. Q J Med (1987) 1.31
Tolerance to penicillin in streptococci of viridans group. J Clin Pathol (1989) 1.30
Scanning electron microscopy of Staphyloccus aureus exposed to some common anti-staphylococcal agents. J Gen Microbiol (1972) 1.25
Potential role of epithelial cell-derived histone H1 proteins in innate antimicrobial defense in the human gastrointestinal tract. Infect Immun (1998) 1.22
Comparative antipseudomonal activity of some newer beta-lactam agents. Antimicrob Agents Chemother (1982) 1.22
An electronmicroscope study of glycopeptide antibiotic-resistant strains of Staphylococcus epidermidis. J Med Microbiol (1993) 1.20
Specific and non-specific resistance to aminoglycosides in Escherichia coli. J Clin Pathol (1978) 1.18
In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin. Antimicrob Agents Chemother (1981) 1.16
Localization of cholinergic and purinergic receptors on outer hair cells isolated from the guinea-pig cochlea. Proc Biol Sci (1992) 1.16
Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance. J Antimicrob Chemother (1984) 1.16
Live high:train low increases muscle buffer capacity and submaximal cycling efficiency. Acta Physiol Scand (2001) 1.13
Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem. J Med Microbiol (1986) 1.13
In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD. J Antimicrob Chemother (1993) 1.09
In vitro model simulating the form of exposure of bacteria to antimicrobial drugs encountered in infection. Antimicrob Agents Chemother (1979) 1.09
Differentiation of mechanisms responsible for inoculum effects in the response of Escherichia coli to a variety of antibiotics. J Antimicrob Chemother (1976) 1.09
The response of Escherichia coli to ciprofloxacin and norfloxacin. J Med Microbiol (1987) 1.08
Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria. J Clin Pathol (1977) 1.07
Shape at the cross-roads: homoplasy and history in the evolution of the carnivoran skull towards herbivory. J Evol Biol (2010) 1.07
Purinergic regulation of sound transduction and auditory neurotransmission. Audiol Neurootol (2002) 1.07
Scanning electronmicroscopy of Staphylococcus aureus and Enterococcus faecalis exposed to daptomycin. J Med Microbiol (1989) 1.07
Antibiotic-induced surface changes in microorganisms demonstrated by scanning electron microscopy. Science (1969) 1.07
Activity of FL 1060, a new beta-lactam antibiotic, against urinary tract pathogens. J Clin Pathol (1974) 1.06
Characterization of beta-lactamases in clinical isolates of Bacteroides. J Antimicrob Chemother (1986) 1.05
A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics. J Infect Dis (1982) 1.04
Cefuroxime: a new cephalosporin antibiotic with enhanced stability to enterobacterial beta-lactamases. J Antimicrob Chemother (1976) 1.04
In-vitro evaluation of sulbactam, a penicillanic acid sulphone with beta-lactamase inhibitory properties. J Antimicrob Chemother (1982) 1.03
The antibacterial activity of hexamine (methenamine), hexamine hippurate and hexamine mandelate. Infection (1981) 1.01
Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder. Br J Exp Pathol (1975) 1.00
An investigation of beta-lactamases from clinical isolates of Bacteroides species. J Med Microbiol (1992) 0.99
Lifestyle factors affecting fruit and vegetable consumption in the UK Women's Cohort Study. Appetite (2001) 0.98
Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst (2001) 0.98
Preserving the miracle of antibiotics. Lancet (1995) 0.98
Comparative growth of Bacteroides species in various anaerobic culture media. J Med Microbiol (1985) 0.97
Dual-action cephalosporin utilizing a novel therapeutic principle. Antimicrob Agents Chemother (1976) 0.97
Activity of a new cephalosporin antibiotic, Ro 13-9904 against dense populations of selected enterobacteria. Antimicrob Agents Chemother (1981) 0.95
The response of Streptococcus faecalis to ciprofloxacin, norfloxacin and enoxacin. J Antimicrob Chemother (1988) 0.95
Expression of ATP-gated ion channels by Reissner's membrane epithelial cells. Neuroreport (1998) 0.94
Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem. J Antimicrob Chemother (1987) 0.92
An in vitro evaluation of clavulanic acid, a potent, broad-spectrum beta-lactamase inhibitor. J Antimicrob Chemother (1979) 0.91
An empirical method for converting nucleolar counts to neuronal numbers. J Neurosci Methods (1984) 0.90
Effect of inoculum size on bacteriolytic activity of cefminox and four other beta-lactam antibiotics against Escherichia coli. Antimicrob Agents Chemother (1992) 0.90
Sexual dimorphism in the numbers of neurons in the pelvic ganglia of adult rats. Brain Res (1985) 0.90
In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli. J Antimicrob Chemother (1981) 0.89
The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin. J Med Microbiol (1984) 0.89
In vitro activity of temocillin, a new beta-lactamase-stable penicillin active against enterobacteria. Antimicrob Agents Chemother (1982) 0.88
The search for a veterinary insecticide. II. Carbamates active against sheep blowfly. J Sci Food Agric (1967) 0.88
Reproducibility of systematic literature reviews on food, nutrition, physical activity and endometrial cancer. Public Health Nutr (2007) 0.88
Effect of osmolality on the response of Escherichia coli to mecillinam. Antimicrob Agents Chemother (1976) 0.88
Activity of cefazolin against dense populations of enterobacteria. Antimicrob Agents Chemother (1975) 0.88
MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations. J Magn Reson Imaging (1997) 0.87
Evidence for alternative splicing of ecto-ATPase associated with termination of purinergic transmission. Brain Res Mol Brain Res (1999) 0.87
Response profiles: A method of evaluating the activity of beta-lactam antibiotics against Enterobacteria. Chemotherapy (1977) 0.86
Turbidimetric response of Staphylococcus aureus and Enterococcus faecalis to daptomycin. Eur J Clin Microbiol Infect Dis (1988) 0.86
Lysis enhancement: a novel form of interaction between beta-lactam antibiotics. J Med Microbiol (1975) 0.86
The activity of polymyxins against dense populations of Escherichia coli. J Gen Microbiol (1975) 0.86
The microbiological and pharmacokinetic profile of an antibacterial agent useful for the single-dose therapy of urinary tract infection. Eur Urol (1987) 0.85
Identification of a short form of the P2xR1-purinoceptor subunit produced by alternative splicing in the pituitary and cochlea. Biochem Biophys Res Commun (1995) 0.85
Factors influencing the response of Escherichia coli to antibiotics in conditions prevailing in the infected urinary bladder. Br J Exp Pathol (1976) 0.85
The trometamol salt of fosfomycin: microbiological evaluation. Eur Urol (1987) 0.83
Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infection. J Antimicrob Chemother (1978) 0.83
Measurement of perceived disruption during rebuilding following Hurricane Andrew. J Trauma Stress (1997) 0.83
In vitro activity against Escherichia coli of CGP 9000, a new oral cephalosporin. J Antibiot (Tokyo) (1978) 0.83
Phenotypic resistance to antimicrobial agents. J Antimicrob Chemother (1985) 0.83
Activity of teicoplanin against gram-negative anaerobes. J Antimicrob Chemother (1988) 0.83
Interactions between antibacterial agents of the quinolone group and nitrofurantoin. J Antimicrob Chemother (1988) 0.82
Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid. J Antimicrob Chemother (1985) 0.82
Levels of malondialdehyde-deoxyguanosine in the gastric mucosa: relationship with lipid peroxidation, ascorbic acid, and Helicobacter pylori. Cancer Epidemiol Biomarkers Prev (2001) 0.81
Factors governing the emergence of resistance to nalidixic acid in treatment of urinary tract infection. Antimicrob Agents Chemother (1977) 0.81
P2X2 receptor expression by interstitial cells of Cajal in vas deferens implicated in semen emission. Auton Neurosci (2000) 0.81